PhaseBio Pharmaceuticals, Inc. raised $15M Series B venture round, led by New Enterprise Associates.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$68.3M
Top Valuation
-
PhaseBio Pharmaceuticals, Inc. raised $15M in a Series B round.
The round was announced on 12/02/10.
The round was led by New Enterprise Associates.